Novel FAPi Dimers for Broad Theranostic Applications: 225Ac/177Lu/90Y/68Ga-Radiolabeling and in vitro Evaluation

被引:0
|
作者
Martin, M. [1 ]
Van Rymenant, Y. [2 ]
De Loose, J. [2 ]
Verhulst, E. [2 ]
Van der Veken, P. [2 ]
De Meester, I. [2 ]
Roesch, F. [1 ]
机构
[1] TRIGA site, Dept Chem, Mainz, Germany
[2] Dept Pharmaceut Sci, Antwerp, Belgium
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EPS-069
引用
收藏
页码:S326 / S327
页数:2
相关论文
共 10 条
  • [1] Preclinical evaluation of novel theranostic heterodimeric ligands [68Ga]Ga/[177Lu]Lu-DOTA-FAPI-BPsfor tumor bone metastasis
    Deng, Y.
    Jin, W.
    Zhang, Z.
    Wang, X.
    Zhao, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S450 - S450
  • [2] Synthesis and comparative biological evaluation of bifunctional ligands for radiotherapy applications of 90Y and 177Lu
    Chong, Hyun-Soon
    Sun, Xiang
    Chen, Yunwei
    Sin, Inseok
    Kang, Chi Soo
    Lewis, Michael R.
    Liu, Dijie
    Ruthengael, Varyanna C.
    Zhong, Yongliang
    Wu, Ningjie
    Song, Hyun A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (05) : 1169 - 1178
  • [3] 44Sc and 68Ga versus 90Y and 177Lu labelled DOTA-Bombesin and its in vitro evaluation in PC-3 cells
    Koumarianou, E.
    Mikolajczak, R.
    Pawlak, D.
    Roesch, F.
    Laktionova, N.
    Zikos, X.
    Archimandritis, S. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S309 - S309
  • [4] Comparison of PSMA-TO-1 and PSMA-617 labelled with 68Ga, 177Lu and 225Ac: a first in-human translational study
    Meyer, C.
    Prasad, V.
    Stuparu, A.
    Glatting, G.
    Kletting, P.
    Miksch, J.
    Solbach, C.
    Lueckerath, K.
    Nyiranshuti, L.
    Zhu, S.
    Czernin, J.
    Dahlbom, M.
    Calais, J.
    Beer, A.
    Slavik, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S43 - S43
  • [5] Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation
    Koumarianou, Eftychia
    Mikolajczak, Renata
    Pawlak, Dariusz
    Zikos, Xhristos
    Bouziotis, Pinelopi
    Garnuszek, Piotr
    Karczmarczyk, Urszula
    Maurin, Michal
    Archimandritis, Spyridon C.
    NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (06) : 591 - 603
  • [6] Concurrent use of 90Y, 177Lu and 225Ac-labelled PSMA-binding radiopharmaceuticals can lead to improved treatment efficacy
    Denis-Bacelar, A. M.
    Fenwick, A. J.
    Ferreira, K. M.
    Wevrett, J. L.
    Robinson, A. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S271 - S272
  • [7] Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [68Ga]Ga/[177Lu]Lu-NYM032 for theranostic use in prostate cancer
    Fu, Haitian
    He, Huihui
    Wang, Yanjuan
    Li, Wenjin
    Luo, Yihui
    Chen, Liping
    Mi, Yuanyuan
    Sun, Chengwen
    Mao, Yong
    Yu, Chunjing
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, : 1671 - 1684
  • [8] Preparation, Radiolabeling with 68Ga/177Lu and Preclinical Evaluation of Novel Angiotensin Peptide Analog: A New Class of Peptides for Breast Cancer Targeting
    Okarvi, Subhani M.
    PHARMACEUTICALS, 2023, 16 (11)
  • [9] [68Ga]FAPI-46, [18F]FDG and [68Ga]PSMA-11 PET/CT findings in advance stage castration resistant metastatic prostate carcinoma treated with tandem radionuclide [225Ac]/[177Lu]PSMA-617: Two case reports
    Novruzov, F.
    Mehdi, E.
    Dadashov, Z.
    Moore, M.
    Valla, F.
    Tahirov, T.
    Giammarile, F.
    Guliyev, F.
    Aliyev, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S571 - S572
  • [10] Pyridine-containing octadentate ligand NE3TA-PY for formation of neutral complex with 177Lu(III) and 90Y(III) for radiopharmaceutical applications: Synthesis, DFT calculation, radiolabeling, and in vitro complex stability
    Chong, Hyun-Soon
    Chen, Yunwei
    Kang, Chi Soo
    Sin, Inseok
    Zhang, Shuyuan
    Wang, Haixing
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2021, 221